Canine Osteosarcoma
- 1 January 1996
- journal article
- review article
- Published by Elsevier in Veterinary Clinics of North America: Small Animal Practice
- Vol. 26 (1) , 123-133
- https://doi.org/10.1016/s0195-5616(96)50011-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Current Studies of Liposome Muramyl Tripeptide (CGP 19835A Lipid) Therapy for Metastasis in Spontaneous Tumors: A Progress Review*Journal of Drug Targeting, 1994
- In vitro and in vivo canine mononuclear cell production of tumor necrosis factor induced by muramyl peptides and lipopolysaccharideVeterinary Immunology and Immunopathology, 1993
- Muramyl Peptides Augment the In Vitro and In Vivo Cytostatic Activity of Canine Plastic-Adherent Mononuclear Cells Against Canine Osteosarcoma CellsCancer Biotherapy, 1993
- Unique histological changes in lung metastases of osteosarcoma patients following therapy with liposomal muramyl tripeptide (CGP 19835A lipid)Cancer Immunology, Immunotherapy, 1992
- Comparative Aspects of OsteosarcomaClinical Orthopaedics and Related Research, 1991
- Therapy for Osteosarcoma in Dogs With Intravenous Injection of Liposome-Encapsulated Muramyl TripeptideJNCI Journal of the National Cancer Institute, 1989
- Canine OsteosarcomaJournal of Veterinary Internal Medicine, 1988
- Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.Journal of Clinical Investigation, 1983
- The Pulmonary-Alveolar MacrophageNew England Journal of Medicine, 1979
- Direct Evidence for a Bone Marrow Origin of the Alveolar Macrophage in ManScience, 1976